Free tool
Diagnostics stocks
We cover 52 companies grouped under the Diagnostics theme. The median market value in the group is $535.49M. Across the group, the median move over the past trading day is −0.52%. 51% of the 51 with a 200-day average trade above it. Price change over the past year runs from −45.5% to +100.9% across the middle 80 percent of the group, with a median of −7.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
52 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% |
| BIM.PA | bioMérieux S.A. | $10.22B | Large cap | −35.91% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% |
| SHL.AX | Sonic Healthcare Limited | $7.14B | Mid cap | −11.84% |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +2.77% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% |
| 4694.T | BML, Inc. | $851.50M | Small cap | +5.42% |
| IDX.AX | Integral Diagnostics Limited | $638.89M | Small cap | −19.60% |
| DASA3.SA | Diagnósticos da América S.A. | $633.57M | Small cap | +93.33% |
| FLGT | Fulgent Genetics, Inc. | $545.08M | Small cap | −8.46% |
| 137310.KS | SD Biosensor, Inc. | $525.90M | Small cap | −38.35% |
| 4549.T | Eiken Chemical Co., Ltd. | $486.14M | Small cap | −5.16% |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% |
| VOX.WA | Voxel S.A. | $376.42M | Small cap | −18.11% |
| ACL.AX | Australian Clinical Labs Limited | $373.98M | Small cap | +5.46% |
| N3B.F | Anbio Biotechnology | $361.87M | Small cap | −83.42% |
| NNNN | Anbio Biotechnology | $343.67M | Small cap | −83.55% |
| 197A.T | TAUNS LABORATORIES INC. | $338.11M | Small cap | −11.13% |
| SBS.DE | Stratec SE | $322.43M | Small cap | −16.91% |
| IDHC.L | Integrated Diagnostics Holdings plc | $298.80M | Small cap | +16.89% |
| MYGN | Myriad Genetics, Inc. | $298.43M | Small cap | −47.39% |
| OSUR | OraSure Technologies, Inc. | $255.87M | Small cap | +11.08% |
| HLS.AX | Healius Limited | $233.27M | Small cap | −50.55% |
| ALERS.PA | Eurobio Scientific Société anonyme | $232.43M | Small cap | −21.89% |
| 4595.T | Mizuho Medy Co.,Ltd. | $207.18M | Small cap | +11.63% |
| LUCD | Lucid Diagnostics Inc. | $185.35M | Small cap | −22.96% |
| PEB.AX | Pacific Edge Limited | $182.42M | Small cap | +60.00% |
| S2B.WA | Syn2bio S.A. | $151.66M | Small cap | +76.47% |
| EKF.L | EKF Diagnostics Holdings plc | $145.56M | Small cap | −15.56% |
| IMDX | Insight Molecular Diagnostics Inc. | $145.30M | Small cap | +73.39% |
| SCP.WA | Scope Fluidics S.A. | $120.06M | Small cap | −9.90% |
| S84.F | Scope Fluidics S.A. | $118.77M | Small cap | −10.43% |
| QUCY | Quantum Cyber N.V. | $115.59M | Small cap | −15.12% |
| BNR | Burning Rock Biotech Limited | $110.10M | Small cap | +22.54% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $105.23M | Small cap | −60.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.